ZIF series photocatalyst and preparation method thereof

By adjusting the coordination reaction of ZIF-8 photocatalyst and using a variety of organic ligands to improve its photocatalytic performance, the problem of low light absorption efficiency and activity of ZIF-8 photocatalyst is solved, and more efficient photocatalytic reactions are achieved. Hydrogen production efficiency.

CN118994611AInactive Publication Date: 2024-11-22TIANJIN UNIV OF SCI & TECH
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202410914664.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-09
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing ZIF-8 photocatalysts have problems with low light absorption efficiency and low activity, which limits their effectiveness in practical applications.

Method used

Two organic ligands are used for coordination reaction with inorganic salts, one of which is the traditional 2-methylimidazole, and the other is the substituted or unsubstituted imidazole, pyridine, pyrimidine, Pyrazine or oxazole, by adjusting the ratio and reaction conditions, ZIF series photocatalysts are prepared, maintaining structural stability and improving photogenerated carrier recombination rate and light absorption capacity.

Benefits of technology

The photocatalytic reaction rate and hydrogen production efficiency are improved, and the hydrogen production activity of the photocatalyst is simple to operate and low cost.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994611A_ABST
    Figure CN118994611A_ABST
Patent Text Reader

Abstract

The invention relates to the field of photocatalysis, in particular to a ZIF series photocatalyst and a preparation method thereof. The preparation method of the ZIF-series photocatalyst comprises the following steps: carrying out coordination reaction on inorganic salt capable of providing zinc ions, a first organic ligand and a second organic ligand in a reaction medium to obtain the ZIF-series photocatalyst, the first organic ligand is 2-methylimidazole; the second organic ligand is imidazole, pyridine, pyrimidine, pyrazine, pyridazine or oxazole of which the first position or the second position is substituted or unsubstituted; the second organic ligand and the first organic ligand are different compounds; the reaction medium is water or alcohol. The ZIF series photocatalyst prepared by the method has a stable structure, the forbidden band width is reduced to a certain extent, the problem of high recombination rate of photon-generated carriers is improved, and the photocatalytic reaction rate and the hydrogen production efficiency are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of photocatalysis, and in particular to a ZIF series photocatalyst and a preparation method thereof. Background Art

[0002] Photocatalysts are materials that can utilize light energy to stimulate catalytic reactions. They can convert light energy into chemical energy and are widely used in processes such as degradation of organic pollutants, water decomposition to produce hydrogen, and CO2 reduction. Photocatalysts have a wide range of applications in environmental protection, energy, and chemical industries.

[0003] The ZIF series of photocatalysts, i.e., zeolite-like imidazolate framework materials, are MOF materials with zeolite structures synthesized by reacting Zn(II) or Co(II) with imidazole ligands. The ZIF-8 photocatalyst is a porous material formed by the coordination bond between Zn(II) and 2-methylimidazole ligands. It has a special microporous structure. Compared with other similar catalysts, the ZIF-8 photocatalyst has the advantages of high specific surface area, good chemical stability and excellent optical properties. The traditional ZIF-8 photocatalyst is synthesized by Zn(II) and 2-methylimidazole ligands in anhydrous methanol. The zinc ions are combined with 2-methylimidazole ligands through coordination bonds to form ZIF-8 crystals with a porous structure. However, the existing ZIF-8 photocatalysts have the problems of low light absorption efficiency and low activity, which limits their effectiveness in practical applications. Summary of the invention

[0004] In order to solve or partially solve the problems existing in the related art, the present invention provides a ZIF series photocatalyst and a preparation method thereof.

[0005] The present invention provides a method for preparing a ZIF series photocatalyst, which comprises:

[0006] The inorganic salt of zinc ion can be provided to react with the first organic ligand and the second organic ligand in the reaction medium to obtain a ZIF series photocatalyst;

[0007] The first organic ligand is 2-methylimidazole; the second organic ligand is imidazole, pyridine, pyrimidine, pyrazine, pyridazine or oxazole which is substituted or unsubstituted at the 1st or 2nd position; the second organic ligand and the first organic ligand are different compounds;

[0008] The reaction medium is water or alcohol.

[0009] Furthermore, the inorganic salt is zinc nitrate, zinc acetate, zinc chloride or zinc sulfate.

[0010] Further, the second organic ligand is 1-ethylimidazole, 1-vinylimidazole, 1-phenylimidazole, 1-isopropylimidazole, 1-hexylimidazole, 2-methylbenzimidazole, 2-ethylbenzimidazole, 2-aminobenzimidazole, 2-methylpyridine, 2-ethylpyridine, 2-vinylpyridine, 2-2'-bipyridine, 2-phenylpyridine, 2-fluoropyridine, 2-aminopyrimidine, 2-fluoropyrimidine or oxazole.

[0011] Furthermore, the molar ratio of the inorganic salt to the first organic ligand is 1:1-30; the molar ratio of the second organic ligand to the first organic ligand is 1:0.1-30.

[0012] Furthermore, the inorganic salt is zinc nitrate; and the second organic ligand is 2,2'-bipyridine or 1-vinylimidazole.

[0013] Further, the second organic ligand is 2,2'-bipyridine, the molar ratio of the inorganic salt to the first organic ligand is 1:8, and the molar ratio of the second organic ligand to the first organic ligand is 1:7; or,

[0014] The second organic ligand is 1-vinyl imidazole, the molar ratio of the inorganic salt to the first organic ligand is 1:8, and the molar ratio of the second organic ligand to the first organic ligand is 1:7.

[0015] Furthermore, the reaction medium is deionized water or anhydrous methanol.

[0016] Furthermore, the preparation method is specifically as follows:

[0017] dissolving an inorganic salt capable of providing zinc ions in a reaction medium to obtain a salt solution;

[0018] dissolving the first organic ligand and the second organic ligand in a reaction medium to obtain an organic ligand solution;

[0019] The organic ligand solution is mixed with the salt solution and reacted under stirring;

[0020] The reaction products are centrifuged, washed and dried in sequence to obtain ZIF series photocatalysts.

[0021] Furthermore, the reaction time is 10 to 800 minutes.

[0022] The present invention also provides a ZIF series photocatalyst, which is prepared according to any one of the methods described above.

[0023] The ZIF series photocatalysts and preparation methods provided by the present invention have the following beneficial effects:

[0024] 1. This application uses two organic ligands to coordinate with inorganic salts, one of which is the traditional 2-methylimidazole, and the other is substituted or unsubstituted imidazole, pyridine, pyrimidine, pyrazine, pyridazine or oxazole at position 1 or 2. Compared with the traditional ZIF-8 photocatalyst, the ZIF series photocatalyst prepared using the above two ligands has a stable structure and improves the problem of high recombination rate of photogenerated carriers, which helps to improve the photocatalytic reaction rate and hydrogen production efficiency.

[0025] 2. The preparation method provided in this application does not destroy the original topological structure and rich pore structure of the ZIF-8 semiconductor material. It not only maintains the structural advantages of the ZIF-8 material, but also reduces the bandgap width to a certain extent, improves the disadvantage of insufficient light absorption capacity of ZIF-8, and is beneficial to improving the efficiency of photocatalytic hydrogen production.

[0026] 3. The preparation method provided in this application is simple to operate, has mild reaction conditions, is easy to implement, and has low cost.

[0027] It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] The above and other objects, features and advantages of the present invention will become more apparent through a more detailed description of exemplary embodiments of the present invention in conjunction with the accompanying drawings, wherein like reference numerals generally represent like components throughout the exemplary embodiments of the present invention.

[0029] Figure 1 It is a scanning electron microscope image of the photocatalyst prepared in Comparative Example 1 and Examples 15, 16 and 17 of the present application;

[0030] Figure 2 is a scanning electron microscope image of the photocatalyst prepared in Examples 18 to 21 of the present application;

[0031] Figure 3 It is a scanning electron microscope image of the photocatalyst prepared in Comparative Example 2 and Examples 8, 12, 7, 6 and 5 of the present application. DETAILED DESCRIPTION

[0032] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0033] The terms used in the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The singular forms "a", "the" and "the" used in the present invention and the appended claims are also intended to include plural forms unless the context clearly indicates other meanings. It should also be understood that the term "and / or" used herein refers to and includes any or all possible combinations of one or more associated listed items.

[0034] It should be understood that although the terms "first", "second", "third", etc. may be used to describe various information in the present invention, such information should not be limited to these terms. These terms are only used to distinguish the same type of information from each other. For example, without departing from the scope of the present invention, the first information may also be referred to as the second information, and similarly, the second information may also be referred to as the first information. Thus, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features. In the description of the present invention, the meaning of "multiple" is two or more, unless otherwise clearly and specifically defined.

[0035] The inventors of this application consider that organic ligands have certain influences on the bandgap width, photogenerated carrier recombination ability and morphology structure of ZIF series photocatalysts, therefore, first consider improving the existing organic ligands in the hope of optimizing the hydrogen production activity of ZIF series photocatalysts. The inventors further found that 2-methylimidazole has an important influence on the formation and stability of the material skeleton, therefore, the inventors consider adding other organic ligands, i.e., second organic ligands, on the basis of retaining 2-methylimidazole, in the hope of shortening the bandgap width of the photocatalyst, and / or, inhibiting the recombination ability of photogenerated carriers, thereby improving the hydrogen production activity of the catalyst.

[0036] For the added second organic ligand, the inventors considered using a polycyclic or heterocyclic ring containing N. However, the inventors found that after adding a polycyclic or heterocyclic organic ligand containing N, the structure of some products was unstable, or did not shorten the bandgap. In this regard, the inventors further studied and found that the above problems can be solved by using 1 or 2 substituted or unsubstituted imidazole, pyridine, pyrimidine, pyrazine, pyridazine or oxazole. Therefore, the present application embodiment provides a method for preparing a ZIF series photocatalyst, which comprises:

[0037] The inorganic salt of zinc ion can be provided to react with the first organic ligand and the second organic ligand in the reaction medium to obtain a ZIF series photocatalyst;

[0038] The first organic ligand is 2-methylimidazole; the second organic ligand is imidazole, pyridine, pyrimidine, pyrazine, pyridazine or oxazole which is substituted or unsubstituted at the 1st or 2nd position; the second organic ligand and the first organic ligand are different compounds;

[0039] The reaction medium is water or alcohol.

[0040] In the preparation method of the ZIF series photocatalyst provided in the present embodiment, the above-mentioned inorganic salt is used to provide zinc ions, and the inorganic salt is preferably zinc nitrate, zinc acetate, zinc chloride or zinc sulfate. Organic ligands are used to coordinate with zinc ions, and then these metal organic coordination compounds form metal organic framework structures by self-assembly. Different from the prior art, the present application adopts two organic ligands to coordinate with inorganic salts, one of which is traditional 2-methylimidazole, and the other is 1 or 2 substituted or unsubstituted imidazole, pyridine, pyrimidine, pyrazine, pyridazine or oxazole. Relative to the traditional ZIF-8 photocatalyst, the ZIF series photocatalyst prepared using the above two ligands has a stable structure, and the bandgap width is reduced to a certain extent, while improving the problem of high recombination rate of photogenerated carriers, which helps to improve the photocatalytic reaction rate and hydrogen production efficiency.

[0041] The addition of the above-mentioned second organic ligand, on the one hand, can reduce the recombination of the photogenerated carriers of the catalyst, so that the photocatalytic activity is improved; on the other hand, it can shorten the bandgap and improve the light absorption capacity of the catalyst; these two aspects are beneficial to improving the hydrogen production activity of the photocatalyst. However, the inventors of the present application have found that in some cases, the addition of the second organic ligand will lead to a decrease in the conduction band position, which reduces the reaction driving force for the generation of hydrogen, thus affecting the improvement of the photocatalytic activity to a certain extent, showing a phenomenon that the improvement of the photocatalytic activity is not obvious. The inventors of the present application further found that the raw material ratio and the structure of the second coordination compound have an impact on the occurrence of the above-mentioned conduction band position decrease. For this reason, the inventors of the present application have solved the above-mentioned problems by screening the second organic ligand and further adjusting the raw material ratio. Specifically:

[0042] The second organic ligand is preferably 1-ethylimidazole, 1-vinylimidazole, 1-phenylimidazole, 1-isopropylimidazole, 1-hexylimidazole, 2-methylbenzimidazole, 2-ethylbenzimidazole, 2-aminobenzimidazole, 2-methylpyridine, 2-ethylpyridine, 2-vinylpyridine, 2-2'-bipyridine, 2-phenylpyridine, 2-fluoropyridine, 2-aminopyrimidine, 2-fluoropyrimidine or oxazole. Further, the molar ratio of the inorganic salt to the first organic ligand is preferably 1:1-30, and the molar ratio of the second organic ligand to the first organic ligand is preferably 1:0.1-30. More preferably, the molar ratio of the inorganic salt to the first organic ligand is 1:4-15, and the molar ratio of the second organic ligand to the first organic ligand is 1:0.5-10. Further preferably, the molar ratio of the inorganic salt to the first organic ligand is 1:8-11, and the molar ratio of the second organic ligand to the first organic ligand is 1:1-9.

[0043] Under the aforementioned ratio conditions, the inorganic salt is zinc nitrate, and the second ligand is 2,2'-bipyridine or 1-vinylimidazole, which has a higher hydrogen production activity. Therefore, it is more preferred that the inorganic salt is zinc nitrate, and the second ligand is 2,2'-bipyridine or 1-vinylimidazole, and 2,2'-bipyridine is most preferred. Zinc nitrate can specifically be Zn(NO3)2·6H2O. When the second ligand is 2,2'-bipyridine, the molar ratio of the inorganic salt to the first organic ligand is most preferably 1:8, and the molar ratio of the second organic ligand to the first organic ligand is most preferably 1:7. When the second ligand is 1-vinylimidazole, the molar ratio of the inorganic salt to the first organic ligand is most preferably 1:8, and the molar ratio of the second organic ligand to the first organic ligand is most preferably 1:7.

[0044] The reaction medium in the above preparation method is water or alcohol, preferably deionized water or anhydrous methanol. Anhydrous methanol is advantageous for obtaining products with rhombic dodecahedral morphology, while deionized water is advantageous for obtaining products with two-dimensional layered structures or polyhedral morphology.

[0045] The preparation method of this embodiment can be specifically as follows:

[0046] dissolving an inorganic salt capable of providing zinc ions in a reaction medium to obtain a salt solution;

[0047] dissolving the first organic ligand and the second organic ligand in a reaction medium to obtain an organic ligand solution;

[0048] The organic ligand solution is mixed with the salt solution and reacted under stirring;

[0049] The reaction products are centrifuged, washed and dried in sequence to obtain ZIF series photocatalysts.

[0050] In the above preparation method, the inorganic salt and the two organic ligands are first dissolved in the reaction medium respectively to obtain a salt solution and an organic ligand solution, and then the two are mixed and reacted under stirring. In order to promote the full dissolution of the inorganic salt, the inorganic salt can be dissolved and added to the reaction medium for ultrasonication to obtain a salt solution. In the configuration of the above organic ligand solution, the first organic ligand and the second organic ligand in a preset ratio can be mixed first, and then added to the reaction medium, and the organic ligand solution is obtained after full dissolution. After obtaining the configured salt solution and organic ligand solution, the two are mixed and stirred for reaction, and the appropriate stirring speed can increase the hydrogen production activity of the catalyst. If the reaction time is too short, the crystal form of the catalyst is not completely generated, and the hydrogen production activity is low. At this time, extending the stirring time will increase the hydrogen production activity; however, if the reaction time is too long, the catalyst grains will grow too large, resulting in a decrease in hydrogen production activity. In this embodiment, the reaction time is preferably 10 to 800 minutes, and more preferably 0.5 to 28 hours. The stirring speed is preferably 200 to 500 r / min, and most preferably 300 r / min.

[0051] After the reaction is completed, the reaction product needs to be centrifuged to remove unreacted raw materials and solvents; then the solid product after centrifugation is washed with anhydrous methanol or deionized water to remove residual impurities. Finally, the washed photocatalyst is dried to remove methanol or water, and the drying temperature is preferably 60°C. After drying, the ZIF series photocatalyst is obtained.

[0052] Another embodiment of the present invention provides a ZIF series photocatalyst, which is prepared according to the method of the above embodiment. The ZIF series photocatalyst obtained by the above method is a porous material formed by the metal ions and the first organic ligand and the second organic ligand being combined by coordination bonds.

[0053] The ZIF series photocatalysts and preparation methods thereof provided by the present invention have the following advantages:

[0054] 1. This application uses two organic ligands to coordinate with inorganic salts, one of which is the traditional 2-methylimidazole, and the other is substituted or unsubstituted imidazole, pyridine, pyrimidine, pyrazine, pyridazine or oxazole at position 1 or 2. Compared with the traditional ZIF-8 photocatalyst, the ZIF series photocatalyst prepared using the above two ligands has a stable structure and improves the problem of high recombination rate of photogenerated carriers, which helps to improve the photocatalytic reaction rate and hydrogen production efficiency.

[0055] 2. The preparation method provided in this application does not destroy the original topological structure and rich pore structure of the ZIF-8 semiconductor material. It not only maintains the structural advantages of the ZIF-8 material, but also reduces the bandgap width to a certain extent, improves the disadvantage of insufficient light absorption capacity of ZIF-8, and is beneficial to improving the efficiency of photocatalytic hydrogen production.

[0056] 3. The preparation method provided in this application is simple to operate, has mild reaction conditions, is easy to implement, and has low cost.

[0057] The technical solution of the present invention is further described below in conjunction with specific embodiments:

[0058] Comparative Example 1

[0059] Mix Zn(NO3)2·6H2O and 2-methylimidazole in a molar ratio of 1:8. Dissolve 0.59g Zn(NO3)2·6H2O in 40mL anhydrous methanol, named solution A; dissolve 1.30g 2-methylimidazole in 40mL anhydrous methanol, named solution B. Pour solution B into solution A, and stir at 300r / min for 4h. Finally, centrifuge the prepared sample at 8000r / min for 5min, wash with anhydrous methanol 3 times, and dry at 60℃ for 12h.

[0060] Comparative Example 2

[0061] Mix Zn(NO3)2·6H2O and 2-methylimidazole in a mass ratio of 1:3. Dissolve 0.5g Zn(NO3)2·6H2O in 45mL deionized water, named solution A; dissolve 1.50g 2-methylimidazole in 45mL deionized water, named solution B. Stir solution A vigorously at 450r / min on a magnetic stirrer at room temperature for 15 minutes, then pour solution B into solution A. Stir at 300r / min for 0.5h, and a spongy gelatinous substance will appear, then react at this speed for 3.5h. Finally, centrifuge the prepared sample at 8000r / min for 5min, wash with deionized water 3 times, and dry at 60℃ for 12h.

[0062] Example 1

[0063] The difference from Comparative Example 2 is that: Solution B is prepared by dissolving 1.1992 g of 2-methylimidazole and 273 μL of 1-phenylimidazole in 45 mL of deionized water. The molar ratio of 1-phenylimidazole to 2-methylimidazole in Solution B is 1:7. The remaining steps are the same as those in Comparative Example 2.

[0064] Example 2

[0065] The difference from Comparative Example 2 is that: Solution B is prepared by dissolving 1.2851 g of 2-methylimidazole and 216 μL of 1-ethylimidazole in 45 mL of deionized water. The molar ratio of 1-ethylimidazole to 2-methylimidazole in Solution B is 1:7. The remaining steps are the same as those in Comparative Example 2.

[0066] Example 3

[0067] The difference from Comparative Example 2 is that: Solution B is prepared by dissolving 1.2587 g of 2-methylimidazole and 241 μL of 1-isopropylimidazole in 45 mL of deionized water. The molar ratio of 1-isopropylimidazole to 2-methylimidazole in Solution B is 1:7. The remaining steps are the same as those in Comparative Example 2.

[0068] Example 4

[0069] The difference from Comparative Example 2 is that: Solution B is prepared by dissolving 1.1859 g of 2-methylimidazole and 338 μL of 1-hexylimidazole in 45 mL of deionized water. The molar ratio of 1-hexylimidazole to 2-methylimidazole in Solution B is 1:7. The remaining steps are the same as those in Comparative Example 2.

[0070] Example 5

[0071] The difference from Comparative Example 2 is that: Solution B is prepared by dissolving 0.6989 g of 2-methylimidazole and 771 μL of 1-vinylimidazole in 45 mL of deionized water. The molar ratio of 1-vinylimidazole to 2-methylimidazole in Solution B is 1:1. The remaining steps are the same as those in Comparative Example 2.

[0072] Example 6

[0073] The difference from Comparative Example 2 is that: Solution B is prepared by dissolving 1.0853 g of 2-methylimidazole and 399 μL of 1-vinylimidazole in 45 mL of deionized water. The molar ratio of 1-vinylimidazole to 2-methylimidazole in Solution B is 1:3. The remaining steps are the same as those in Comparative Example 2.

[0074] Example 7

[0075] The difference from Comparative Example 2 is that: Solution B is prepared by dissolving 1.2203 g of 2-methylimidazole and 269 μL of 1-vinylimidazole in 45 mL of deionized water. The molar ratio of 1-vinylimidazole to 2-methylimidazole in Solution B is 1:5. The remaining steps are the same as those in Comparative Example 2.

[0076] Example 8

[0077] The difference from Comparative Example 2 is that: Solution B is prepared by dissolving 1.0853 g of 2-methylimidazole and 399 μL of 1-vinylimidazole in 45 mL of deionized water. The molar ratio of 1-vinylimidazole to 2-methylimidazole in Solution B is 1:9. The remaining steps are the same as those in Comparative Example 2.

[0078] Example 9

[0079] The difference from Example 3 is that the stirring reaction time is 0.5 h. The remaining steps are the same as those in Example 3.

[0080] Example 10

[0081] The difference from Example 3 is that the stirring reaction time is 2 hours. The remaining steps are the same as those in Example 3.

[0082] Embodiment 11

[0083] The difference from Example 3 is that the stirring reaction time is 8 hours. The remaining steps are the same as those in Example 3.

[0084] Example 12

[0085] The difference from Example 3 is that the stirring reaction time is 24 hours. The remaining steps are the same as those in Example 3.

[0086] Embodiment 13

[0087] The difference from Example 3 is that the stirring reaction time is 26 hours. The remaining steps are the same as those in Example 3.

[0088] Embodiment 14

[0089] The difference from Example 3 is that the stirring reaction time is 28 hours. The remaining steps are the same as those in Example 3.

[0090] Embodiment 15

[0091] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.2615 g of 2-methylbenzimidazole in 40 mL of anhydrous methanol. The molar ratio of 2-methylbenzimidazole to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0092] Example 16

[0093] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.2893 g of 2-ethylbenzimidazole in 40 mL of anhydrous methanol. The molar ratio of 2-ethylbenzimidazole to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0094] Embodiment 17

[0095] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.2674 g of 2-aminobenzimidazole in 40 mL of anhydrous methanol. The molar ratio of 2-aminobenzimidazole to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0096] Embodiment 18

[0097] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.1843 g of 2-methylpyridine in 40 mL of anhydrous methanol. The molar ratio of 2-methylpyridine to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0098] Embodiment 19

[0099] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.2121 g of 2-ethylpyridine in 40 mL of anhydrous methanol. The molar ratio of 2-ethylpyridine to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0100] Embodiment 20

[0101] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.2081 g of 2-vinylpyridine in 40 mL of anhydrous methanol. The molar ratio of 2-vinylpyridine to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0102] Embodiment 21

[0103] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.3091 g of 2,2'-bipyridine in 40 mL of anhydrous methanol. The molar ratio of 2,2'-bipyridine to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0104] Embodiment 22

[0105] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.0830 g of 2-methylimidazole and 0.4120 g of 2,2'-bipyridine in 40 mL of anhydrous methanol. The molar ratio of 2,2'-bipyridine to 2-methylimidazole in solution B is 1:5. The remaining steps are the same as those in Comparative Example 1.

[0106] Embodiment 23

[0107] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1698 g of 2-methylimidazole and 0.2472 g of 2,2'-bipyridine in 40 mL of anhydrous methanol. The molar ratio of 2,2'-bipyridine to 2-methylimidazole in solution B is 1:9. The remaining steps are the same as those in Comparative Example 1.

[0108] Embodiment 24

[0109] The difference from Example 21 is that the stirring reaction time is 8 hours. The remaining steps are the same as those in Example 21.

[0110] Embodiment 25

[0111] The difference from Example 21 is that the stirring reaction time is 16 hours. The remaining steps are the same as those in Example 21.

[0112] Embodiment 26

[0113] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.1887 g of 2-aminopyrimidine in 40 mL of anhydrous methanol. The molar ratio of 2-aminopyrimidine to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0114] Embodiment 27

[0115] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.1946 g of 2-fluoropyrimidine in 40 mL of anhydrous methanol. The molar ratio of 2-fluoropyrimidine to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0116] Embodiment 28

[0117] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.3079 g of 2-phenylpyridine in 40 mL of anhydrous methanol. The molar ratio of 2-phenylpyridine to 2-methylimidazole in solution B is 1:7, and the remaining steps are the same as those in Comparative Example 1.

[0118] Embodiment 29:

[0119] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.1926 g of 2-fluoropyridine in 40 mL of anhydrous methanol. The molar ratio of 2-fluoropyridine to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0120] Embodiment 30

[0121] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.1383 g of oxazole in 40 mL of anhydrous methanol. The molar ratio of oxazole to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0122] Embodiment 31

[0123] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.1946 g of 2-fluoropyrazine in 40 mL of anhydrous methanol. The molar ratio of 2-fluoropyrazine to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0124] Embodiment 32

[0125] The difference from Comparative Example 1 is that solution B is prepared by dissolving 1.1374 g of 2-methylimidazole and 0.1867 g of 3-methylpyridazine in 40 mL of anhydrous methanol. The molar ratio of 3-methylpyridazine to 2-methylimidazole in solution B is 1:7. The remaining steps are the same as those in Comparative Example 1.

[0126] The ZIF-8 photocatalyst prepared in Comparative Example 1-2 and the ZIF series photocatalyst prepared in Example 1-32 were tested for hydrogen production activity. In order to investigate the effect of photocatalyst materials on the catalytic decomposition of water to produce hydrogen under simulated sunlight, the present application tests the simulated sunlight photocatalytic hydrogen production experiment according to the following method. The test process is as follows: before the reaction starts, the condensation system is turned on, nitrogen is introduced to remove the air in the system, and a 300W xenon lamp is used as a light source. The typical photocatalytic hydrogen production test process is as follows: 20mg of ground photocatalyst is added to 100mL of 0.25mol / L Na2S and 0.35mol / L Na2SO3 solution, 21.6μL 9.519mg / mL chloroplatinic acid solution is transferred with a pipette, and an ultrasonic cleaner is used to ultrasonicate for 5min to form a uniform suspension. Subsequently, the reaction system is operated with nitrogen for 20min to exhaust the air. Next, the reactor was placed on a magnetic stirrer and continuously stirred at a speed of 300 r / min and illuminated for 4 hours to ensure that the photocatalyst was moisturized and evenly dispersed and illuminated evenly during the experiment. The hydrogen content in the gas sample was analyzed by gas chromatograph, and the hydrogen production rate was calculated to be the hydrogen production activity of the photocatalyst.

[0127] The process parameters of the preparation process of the photocatalysts prepared in Comparative Examples 1-2 and Examples 1-32 and the hydrogen production activity of the products are listed in Table 1. In Table 1, Ligand 1 represents the first organic ligand, and Ligand 2 represents the second organic ligand.

[0128] Table 1 Process parameters of photocatalyst preparation process and hydrogen production activity of the product

[0129]

[0130]

[0131] From Table 1, we can see that:

[0132] 1) After the second organic ligand of the present application is added to the raw material, the hydrogen production activity of the photocatalyst is improved.

[0133] 2) When the second organic ligand is 1-vinylimidazole, the molar ratio of the inorganic salt to the first organic ligand is 1:11, and the molar ratio of the second organic ligand to the first organic ligand is 1:7, the activity of the reaction product is higher, and the best activity is 558.04 μmol·g when the reaction time is 24 h. -1 ·h -1 , which is nearly 10 times that of Example 2.

[0134] 3) When the second organic ligand is 2,2'-bipyridine, the molar ratio of the inorganic salt to the first organic ligand is 1:8, the molar ratio of the second organic ligand to the first organic ligand is 1:7, and the reaction time is 24h, the activity of the reaction product is the best, which is 875.61μmol·g -1 ·h -1 , which is nearly 8 times that of comparative example 1.

[0135] 4) When the second organic ligand is added in a certain proportion, the activity of the product is related to the stirring reaction time and the choice of reaction medium. Appropriate stirring can increase the hydrogen production activity of the catalyst. If the reaction time is too short, the catalyst is not fully generated, so the hydrogen production activity will increase with the increase of stirring time; however, stirring for too long will cause the catalyst grains to grow too large, resulting in a decrease in hydrogen production activity. In this application, when the second organic ligand is 1-vinylimidazole and the reaction medium is deionized water, the optimal reaction time is 24h; when the second organic ligand is 2-2'-bipyridine and the reaction medium is anhydrous methanol, the optimal reaction time is 4h.

[0136] The bandgap widths of the photocatalysts prepared in Comparative Examples 1-2 and Examples 5-8, 12, 15-17, 20-21 were tested, and the test results are listed in Table 2:

[0137] Table 2 Bandgap of photocatalysts

[0138] Bandgap Eg(eV) Comparative Example 1 5.06 Comparative Example 2 5.00 Example 5 4.47 Example 6 4.64 Example 7 4.77 Example 8 4.87 Example 12 4.82 Embodiment 15 4.16 Example 16 4.24 Embodiment 17 4.05 Embodiment 20 4.70 Embodiment 21 4.43

[0139] It can be seen from Table 2 that the method of the present application can be used to prepare photocatalysts, which can reduce the band gap and improve the light absorption efficiency, thereby improving the photocatalytic activity.

[0140] The reduction potentials of the photocatalysts of Comparative Example 2, and Examples 5-8 and 12 were tested, and the test results are listed in Table 3:

[0141] Table 3 Reduction potential of photocatalysts

[0142] Reduction potential (eV) Comparative Example 2 -3.11 Example 5 -2.62 Example 6 -2.68 Example 7 -2.87 Example 8 -2.94 Example 12 -2.92

[0143] As shown in Table 3, the reduction potential of the photocatalyst prepared in this application varies from 2.94 eV to -2.62 eV, which is higher than that of H + / H2O potential (~0eV), indicating the possibility of hydrogen production. First, the electrons from the valence band VB (e - ) is excited to reach the conduction band CB and forms a hole (h + ), which proves the formation of electron-hole pairs, and then e - are transferred to the surface of the photocatalyst and react with protons H + The interaction generates hydrogen.

[0144] The scanning electron microscope images of the photocatalysts prepared in Comparative Example 1, Examples 15, 16, and 17 of the present application are as follows: Figure 1 As shown, Figure 1 A, B, C, and D correspond to the photocatalysts prepared in Example 1, Example 15, Example 16, and Example 17, respectively.

[0145] The scanning electron microscope images of the photocatalysts prepared in Examples 18 to 21 of the present application are as follows: Figure 2 As shown, Figure 2 A, B, C, and D correspond to the photocatalysts prepared in Example 18, Example 19, Example 20, and Example 21, respectively.

[0146] The scanning electron microscope images of the photocatalysts prepared in Comparative Example 2 and Examples 8, 12, 7, 6, and 5 of the present application are as follows: Figure 3 As shown, Figure 3 A, B, C, D, E, and F correspond to the photocatalysts prepared in Example 2, Example 8, Example 12, Example 7, Example 6, and Example 5, respectively.

[0147] Depend on Figure 1 and Figure 2 It can be seen that when the reaction medium is anhydrous methanol, ZIF-8 is a rhombic dodecahedron. After the second organic ligand is introduced into the raw material according to the present application, the structure of the rhombic dodecahedron is basically unchanged, but the particle size is changed.

[0148] Depend on Figure 3 It can be seen that when the reaction medium is deionized water, ZIF-8 is a two-dimensional layered structure. After the second organic ligand is introduced into the raw material according to the present application, the morphology changes to a polyhedron.

[0149] The embodiments of the present invention have been described above, and the above description is exemplary, not exhaustive, and is not limited to the disclosed embodiments. Many modifications and changes will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments. The selection of terms used herein is intended to best explain the principles of the embodiments, practical applications, or improvements to the technology in the market, or to enable other persons of ordinary skill in the art to understand the embodiments disclosed herein.

Claims

1. A method for preparing a ZIF series photocatalyst, characterized in that: include: The inorganic salt of zinc ion can be provided to react with the first organic ligand and the second organic ligand in the reaction medium to obtain a ZIF series photocatalyst; The first organic ligand is 2-methylimidazole; the second organic ligand is imidazole, pyridine, pyrimidine, pyrazine, pyridazine or oxazole which is substituted or unsubstituted at the 1st or 2nd position; the second organic ligand and the first organic ligand are different compounds; The reaction medium is water or alcohol.

2. The preparation method according to claim 1, characterized in that: The inorganic salt is zinc nitrate, zinc acetate, zinc chloride or zinc sulfate.

3. The preparation method according to claim 2, characterized in that: The second organic ligand is 1-ethylimidazole, 1-vinylimidazole, 1-phenylimidazole, 1-isopropylimidazole, 1-hexylimidazole, 2-methylbenzimidazole, 2-ethylbenzimidazole, 2-aminobenzimidazole, 2-methylpyridine, 2-ethylpyridine, 2-vinylpyridine, 2-2'-bipyridine, 2-phenylpyridine, 2-fluoropyridine, 2-aminopyrimidine, 2-fluoropyrimidine or oxazole.

4. The preparation method according to claim 3, characterized in that: The molar ratio of the inorganic salt to the first organic ligand is 1:1-30; the molar ratio of the second organic ligand to the first organic ligand is 1:0.1-30.

5. The preparation method according to claim 3, characterized in that: The inorganic salt is zinc nitrate; the second organic ligand is 2,2'-bipyridine or 1-vinyl imidazole.

6. The preparation method according to claim 5, characterized in that: The second organic ligand is 2,2'-bipyridine, the molar ratio of the inorganic salt to the first organic ligand is 1:8, and the molar ratio of the second organic ligand to the first organic ligand is 1:7; or, The second organic ligand is 1-vinyl imidazole, the molar ratio of the inorganic salt to the first organic ligand is 1:8, and the molar ratio of the second organic ligand to the first organic ligand is 1:

7.

7. The preparation method according to claim 1, characterized in that: The reaction medium is deionized water or anhydrous methanol.

8. The preparation method according to claim 1, characterized in that: The preparation method is specifically as follows: dissolving an inorganic salt capable of providing zinc ions in a reaction medium to obtain a salt solution; dissolving the first organic ligand and the second organic ligand in a reaction medium to obtain an organic ligand solution; The organic ligand solution is mixed with the salt solution and reacted under stirring; The reaction products are centrifuged, washed and dried in sequence to obtain ZIF series photocatalysts.

9. The preparation method according to claim 1, characterized in that: The reaction time is 10 to 800 minutes.

10. A ZIF series photocatalyst, characterized in that: It is prepared according to the method according to any one of claims 1 to 9.

Citation Information

Patent Citations

  • Preparation method and application of ligand-doped metal-organic framework hybrid ZIF-8 membrane

    CN111729518A